Dimerizing agent regulated immunoreceptor complexes comprising interleukin receptor signaling domains
Abstract:
The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
Information query
Patent Agency Ranking
0/0